Blue Jet Healthcare — 360° view

Blue Jet Healthcare, a company in the Pharmaceuticals industry, reported revenue of ₹376 crore and net profit of ₹103 crore for the September 2026 quarter.

Blue Jet Healthcare (NSE: BLUEJET) closed at ₹517.60 on 20 Nov 2026, down 10.4% over the past year. Its market capitalisation is ₹9,797 crore and it trades at 34.3 times earnings.

Share price
₹517.60 (20 Nov 2026)
Market cap
₹9,797 Cr (20 Nov 2026)
P/E
34.34 (20 Nov 2026)
Revenue
₹376 Cr (September 2026 quarter)
Net profit
₹103 Cr (September 2026 quarter)
ROCE
26.1% (FY26)
ROE
19.6% (FY26)
Book value
₹121 (FY26)
Dividend yield
0.23% (last 12 months to 20 Nov 2026)
52-week high / low
₹647.80 / ₹325.00 (20 Nov 2026)
1-year return
-10.4% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: BLUEJET

Incorporated in 1968, Blue Jet Healthcare (earlier called Jet Chemicals Pvt Ltd) is a pharmaceutical and healthcare ingredient & intermediate company and the first manufacturer of saccharin and its salts (artificial sweeteners) in India.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.